Literature DB >> 25131442

Short- and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction.

Luciano Consuegra-Sánchez1, Antonio Melgarejo-Moreno2, José Galcerá-Tomás3, Nuria Alonso-Fernández2, Ángela Díaz-Pastor2, Germán Escudero-García2, Leticia Jaulent-Huertas4, Marta Vicente-Gilabert3.   

Abstract

INTRODUCTION AND
OBJECTIVES: The impact of atrial fibrillation on the prognosis of myocardial infarction is still the subject of debate. We analyzed the influence of previous and new-onset atrial fibrillation on in-hospital and long-term prognosis in patients with acute myocardial infarction.
METHODS: Prospective study of 4284 patients with ST-segment elevation acute myocardial infarction. We studied all-cause in-hospital and long-term mortality (median, 7.2 years) using adjusted models.
RESULTS: In total, 3.2% of patients had previous atrial fibrillation and 9.8% had new-onset atrial fibrillation. In general, both groups of patients had a high baseline risk profile and an increased likelihood of in-hospital complications. The crude in-hospital mortality rate was higher in patients with previous atrial fibrillation than in those with new-onset atrial fibrillation (22% vs 12%; P<.001; 30% vs 10%; P<.001). The long-term mortality rate was 11.11/100 patient-years in patients with previous atrial fibrillation and 5.35/100 patient years in those with new-onset atrial fibrillation (both groups, P<.001). New-onset fibrillation alone (odds ratio=1.55; 95% confidence interval, 1.08-2.22) was an independent predictor of in-hospital mortality. Previous atrial fibrillation (hazard ratio=1.24; 95% confidence interval, 0.94-1.64) and new-onset atrial fibrillation (hazard ratio=0.98; 95% confidence interval, 0.80-1.21) were not independent predictors of long-term mortality.
CONCLUSIONS: New-onset atrial fibrillation during hospitalization is an independent risk factor for in-hospital mortality in acute myocardial infarction.
Copyright © 2014 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Fibrilación auricular; Infarto de miocardio; Myocardial infarction; Prognosis; Pronóstico

Mesh:

Year:  2014        PMID: 25131442     DOI: 10.1016/j.rec.2014.03.017

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  5 in total

1.  The 9p21 polymorphism is linked with atrial fibrillation during acute phase of ST-segment elevation myocardial infarction.

Authors:  Marek Kiliszek; Anna Szpakowicz; Maria Franaszczyk; Witold Pepinski; Ewa Waszkiewicz; Malgorzata Skawronska; Rafal Ploski; Anna Niemcunowicz-Janica; Monika Budnik; Dominika Poludniewska; Wlodzimierz Jerzy Musial; Karol Adam Kaminski; Grzegorz Opolski
Journal:  Heart Vessels       Date:  2015-11-28       Impact factor: 2.037

2.  Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation.

Authors:  P Gal; E Parlak; F Demirel; A Adiyaman; J Ten Berg; A W J van 't Hof; A Elvan
Journal:  Neth Heart J       Date:  2015-08       Impact factor: 2.380

Review 3.  High Killips Class as a Predictor of New-onset Atrial Fibrillation Following Acute Myocardial Infarction: Systematic Review and Meta-analysis.

Authors:  En-Yuan Zhang; Li Cui; Zhen-Yu Li; Tong Liu; Guang-Ping Li
Journal:  Chin Med J (Engl)       Date:  2015-07-20       Impact factor: 2.628

4.  The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients.

Authors:  Eero Anttonen; Olli Punkka; Joonas Leivo; Sanjit S Jolly; Vladimír Džavík; Jyri Koivumäki; Minna Tahvanainen; Kimmo Koivula; Kjell Nikus; Jia Wang; John A Cairns; Kari Niemelä; Markku Eskola
Journal:  CJC Open       Date:  2021-06-04

5.  Effect of 2 Different Dosages of Rosuvastatin on Prognosis of Acute Myocardial Infarction Patients with New-Onset Atrial Fibrillation in Jinan, China.

Authors:  Jie Zhang; Ruiqi Feng; Misbahul Ferdous; Bo Dong; Haitao Yuan; Peng Zhao
Journal:  Med Sci Monit       Date:  2020-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.